HCPCS J0895

Injection, deferoxamine mesylate, 500 mg

HCPCS Information

HCPCS Code: J0895
The Healthcare Common Procedure Coding System (HCPCS) is a set of unique alphanumeric codes used to report medical procedures and services to healthcare programs like Medicare and Medicaid. HCPCS codes are used in conjunction with NDC codes for billing and medical documentation puporses. For instance, HCPCS J0895 identifies the type of service or supply used while any of the 14 NDC codes below could be used to specify the exact drug used.
Short Description
Deferoxamine mesylate inj
Long Description
Injection, deferoxamine mesylate, 500 mg
Pricing Indicator
Drugs
Multiple Pricing Indicator
Not applicable as HCPCS priced under one methodology
Coverage Description
Special coverage instructions apply
BETOS Type of Service
Other drugs
Medicare Payment Limit
$9.02
Medicare Co-Insurance Percentage
20.000%
HCPCS Classification
List of HCPCS codes for: Drugs Administered Other Than Oral Method, Chemotherapy Drugs (J-codes)

HCPCS Crossover to NDC Codes

The NDC codes below allow precise billing based on the specific manufacturer and medication used:

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
0078-0467Desferal Deferoxamine MesylateInjection, Powder, Lyophilized, For SolutionIntramuscular; Intravenous; SubcutaneousNovartis Pharmaceuticals CorporationACTIVE
0409-2336Deferoxamine Mesylate Hospira, Inc.
0409-2336Deferoxamine Mesylate Hospira, Inc.
0409-2337Deferoxamine Mesylate Deferoxamine MesylateInjection, Powder, Lyophilized, For SolutionIntramuscular; Intravenous; SubcutaneousHospira, Inc.ACTIVE
0409-2337Deferoxamine Mesylate Hospira, Inc.
47781-623Deferoxamine Mesylate Alvogen Inc.
47781-624Deferoxamine Mesylate Alvogen Inc.
52609-4504Deferoxamine Mesylate Apopharma Usa, Inc.INACTIVATED
52609-4505Deferoxamine Mesylate Apopharma Usa, Inc.INACTIVATED
60505-6236Deferoxamine Mesylate Deferoxamine MesylateInjection, Powder, Lyophilized, For SolutionIntramuscular; Intravenous; SubcutaneousApotex Corp.ACTIVE
60505-6237Deferoxamine Mesylate Deferoxamine MesylateInjection, Powder, Lyophilized, For SolutionIntramuscular; IntravenousApotex Corp.ACTIVE
60505-6238Deferoxamine Mesylate Apotex Corp.
63323-597Deferoxamine Deferoxamine MesylateInjection, Powder, Lyophilized, For SolutionIntramuscular; Intravenous; SubcutaneousFresenius Kabi Usa, LlcACTIVE
63323-599Deferoxamine Deferoxamine MesylateInjection, Powder, Lyophilized, For SolutionIntramuscular; Intravenous; SubcutaneousFresenius Kabi Usa, LlcACTIVE